Cargando…
CD34 is not Expressed by Blasts in a Third of B-ALL Patients and Its Negativity is associated with Aberrant Marker Expression: A Retrospective Analysis
BACKGROUND: CD34 antigen is expressed by early hematopoietic progenitor cells and acute leukemia cells. Its expression is associated with good prognosis in acute myeloid leukemia. Literature is sparse on its prognostic significance in B- acute lymphoblastic leukemia (B-ALL) especially from India. He...
Autores principales: | Garg, Neha, Gupta, Richa, Kotru, Mrinalini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286681/ https://www.ncbi.nlm.nih.gov/pubmed/33773558 http://dx.doi.org/10.31557/APJCP.2021.22.3.919 |
Ejemplares similares
-
Correlation of expression of aberrant immunophenotypic markers in T-ALL with its morphology: A pilot study
por: Garg, Neha, et al.
Publicado: (2018) -
Aberrant myeloid antigen co-expression is correlated with high percentages of CD34-positive cells among blasts of acute lymphoblastic leukemia patients: an Indian tertiary care center perspective
por: Sharma, Rahul Kumar, et al.
Publicado: (2014) -
Validation of Hematological Markers in Early Onset Neonatal Sepsis
por: Rana, Deepshikha, et al.
Publicado: (2022) -
Reaching people through medical humanities: An initiative
por: Gupta, Richa, et al.
Publicado: (2011) -
Mucin-Secreting Gastric Adenocarcinoma with Rhabdoid Areas
por: Sharma, Sonal, et al.
Publicado: (2010)